Response Genetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Mar '15 Mar 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Revenue	16.62	16.72	19.8	18.74	22.64	21.28
Revenue Growth (YoY)	-8.06%	-15.56%	5.68%	-17.25%	6.42%	134.68%
Cost of Revenue	10.37	10.49	10.46	10.42	11.73	10.46
Gross Profit	6.25	6.23	9.35	8.32	10.91	10.82
Selling, General & Admin	18.37	17.99	15.68	13.85	15.11	13.71
Research & Development	1.53	1.73	1.61	2.13	1.32	1.61
Operating Expenses	19.9	19.72	17.29	15.98	16.43	15.33
Operating Income	-13.65	-13.49	-7.95	-7.66	-5.52	-4.51
Interest Expense	-1.02	-0.66	-0.09	-0.09	-0.02	-0.01
Interest & Investment Income	-	-	0	0	0	0
Currency Exchange Gain (Loss)	-0.03	-0.03	0.02	-0.01	-	-
Other Non Operating Income (Expenses)	0	-0	-	-	-	-
EBT Excluding Unusual Items	-14.69	-14.18	-8.02	-7.76	-5.55	-4.52
Gain (Loss) on Sale of Assets	0	0	-	-	-	-
Asset Writedown	-	-	-	-	-0.16	-0.37
Other Unusual Items	0.48	0.48	-	-	-	0.22
Pretax Income	-14.21	-13.7	-8.02	-7.76	-5.7	-4.67
Income Tax Expense	-	-	-	-	-	0
Net Income	-14.21	-13.7	-8.02	-7.76	-5.7	-4.67
Net Income to Common	-14.21	-13.7	-8.02	-7.76	-5.7	-4.67
Shares Outstanding (Basic)	39	39	33	27	19	18
Shares Outstanding (Diluted)	39	39	33	27	19	18
Shares Change (YoY)	10.91%	15.75%	25.20%	39.83%	7.49%	34.01%
EPS (Basic)	-0.37	-0.35	-0.24	-0.29	-0.30	-0.26
EPS (Diluted)	-0.37	-0.35	-0.24	-0.29	-0.30	-0.26
Free Cash Flow	-13.11	-14.35	-7.12	-8.44	-5.41	-6.88
Free Cash Flow Per Share	-0.34	-0.37	-0.21	-0.32	-0.28	-0.39
Gross Margin	37.60%	37.25%	47.20%	44.41%	48.18%	50.83%
Operating Margin	-82.16%	-80.67%	-40.13%	-40.87%	-24.40%	-21.19%
Profit Margin	-85.54%	-81.93%	-40.51%	-41.40%	-25.18%	-21.95%
Free Cash Flow Margin	-78.89%	-85.82%	-35.94%	-45.03%	-23.89%	-32.35%
EBITDA	-12.84	-12.66	-7.31	-7.19	-5.16	-4.04
EBITDA Margin	-77.26%	-75.72%	-36.93%	-38.36%	-22.78%	-19.00%
D&A For EBITDA	0.81	0.83	0.63	0.47	0.37	0.47
EBIT	-13.65	-13.49	-7.95	-7.66	-5.52	-4.51
EBIT Margin	-82.16%	-80.67%	-40.13%	-40.87%	-24.40%	-21.19%
Advertising Expenses	-	0.06	0.02	0.01	0.1	0.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.